Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, Carmen Valenzuela, Raúl Santana et al.|ACS Pharmacology & Translational Science|2020Cited by 45
Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With HeberprovacJesús A. Junco, Marta Ayala, Ranfis Rodríguez et al.|Frontiers in Oncology|2019Cited by 19
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles et al.|medRxiv|2020Cited by 5